Airborne transmission of highly pathogenic H7N1 influenza virus in ferrets

Journal of Virology

Volumn 88, Issue 12, 2014, Pages 6623-6635

  Sutton, Troy C ^a,b   Finch, Courtney ^a,b   Shao, Hongxia ^a,b,d   Angel, Matthew ^a,b   Chen, Hongjun ^a,b   Capua, Ilaria ^c   Cattoli, Giovanni ^c   Monne, Isabella ^c   Pereza, Daniel R ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

^d YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

AIRBORNE VIRUS; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; FERRET; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLUENZA VIRUS A H7N1; MORPHOLOGICAL ADAPTATION; MUTATION; NONHUMAN; NUCLEIC ACID STRUCTURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS CULTURE; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADAPTATION, PHYSIOLOGICAL; AIR MICROBIOLOGY; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FERRETS; HUMANS; INFLUENZA A VIRUS, H7N1 SUBTYPE; INFLUENZA, HUMAN; SERIAL PASSAGE; VIRULENCE;

EID: 84901291255     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02765-13     Document Type: Article

References (70)

1. Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p 1648-1692. In Knipe DM, HowleyPM(ed), Fields virology, 5th ed, vol 1. Lippincott Williams and Wilkins, Philadelphia, PA.
2. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, Koch G, Bosman A, Koopmans M, Osterhaus AD. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. U. S. A. 101:1356-1361. http://dx.doi.org/10.1073/pnas.0308352100.
3. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Meijer A, van Steenbergen J, Fouchier R, Osterhaus A, Bosman A. 2004. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587-593. http://dx.doi.org/10.1016/S0140-6736(04)15589-X.
4. Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, Li Y, Katz J, Krajden M, Tellier R, Halpert C, Hirst M, Astell C, Lawrence D, Mak A. 2004. Human illness from avian influenza H7N3, British Columbia. Emerg. Infect. Dis. 10:2196-2199. http://dx.doi.org/10.3201/eid1012.040961.
5. Belser JA, Davis CT, Balish A, Edwards LE, Zeng H, Maines TR, Gustin KM, Martinez IL, Fasce R, Cox NJ, Katz JM, Tumpey TM. 2013. Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis. J. Virol. 87:5746-5754. http://dx.doi.org/10.1128/JVI.00154-13.
6. WHO. 2013. Report 8: number of confirmed human cases of avian influenza A(H7N9) reported to the WHO. World Health Organization, Geneva, Switzerland.
7. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Chan KH, Tsoi HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li L, Yuen KY. 2013. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381:1916-1925. http://dx.doi.org/10.1016/S0140-6736(13)60903-4.
8. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. 2013. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368:1888-1897. http://dx.doi.org/10.1056/NEJMoa1304459.
9. WHO. 2014. Human infection with avian influenza A(H7N9) virus- update. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/don/2014_04_04/en/.
10. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, Wong SS, Farooqui A, Wang J, Banner D, Chen R, Zheng R, Zhou J, Zhang Y, Hong W, Dong W, Cai Q, Roehrl MH, Huang SS, Kelvin AA, Yao T, Zhou B, Chen X, Leung GM, Poon LL, Webster RG, Webby RJ, Peiris JS, Guan Y, Shu Y. 2013. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341: 183-186. http://dx.doi.org/10.1126/science.1239844.
11. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y, Takashita E, McBride R, Noda T, Hatta M, Imai H, Zhao D, Kishida N, Shirakura M, de Vries RP, Shichinohe S, Okamatsu M, Tamura T, Tomita Y, Fujimoto N, Goto K, Katsura H, Kawakami E, Ishikawa I, Watanabe S, Ito M, Sakai-Tagawa Y, Sugita Y, Uraki R, Yamaji R, Eisfeld AJ, Zhong G, Fan S, Ping J, Maher EA, Hanson A, Uchida Y, Saito T, Ozawa M, Neumann G, Kida H, Odagiri T, Paulson JC, Hasegawa H, Tashiro M, Kawaoka Y. 2013. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551-555. http://dx.doi.org/10.1038/nature12392.
12. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, Sun X, Carney PJ, Villanueva JM, Stevens J, Katz JM, Tumpey TM. 2013. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501:556-559. http://dx.doi.org/10.1038/nature12391.
13. Johnson NP, Mueller J. 2002. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull. Hist Med. 76:105-115. http://dx.doi.org/10.1353/bhm.2002.0022.
14. Potter CW. 2001. A history of influenza. J. Appl. Microbiol. 91:572-579. http://dx.doi.org/10.1046/j.1365-2672.2001.01492.x.
15. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche- Aranda C, Hernandez M, Miller MA. 2009. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N. Engl. J. Med. 361: 674-679. http://dx.doi.org/10.1056/NEJMoa0904023.
16. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541. http://dx.doi.org/10.1126/science.1213362.
17. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-428. http://dx.doi.org/10.1038/nature10831.
18. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, van de Vijver D, Boucher CA, Koopmans M, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA. 2009. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325:481-483. http://dx.doi.org/10.1126/science.1177127.
19. de Wit E, Munster VJ, van Riel D, Beyer WE, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA. 2010. Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J. Virol. 84:1597-1606. http://dx.doi.org/10.1128/JVI.01783-09.
20. Hatta M, Gao P, Halfmann P, Kawaoka Y. 2001. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840-1842. http://dx.doi.org/10.1126/science.1062882.
21. Subbarao EK, London W, Murphy BR. 1993. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J. Virol. 67:1761-1764.
22. Capua I, Mutinelli F, Pozza MD, Donatelli I, Puzelli S, Cancellotti FM. 2002. The 1999-2000 avian influenza (H7N1) epidemic in Italy: veterinary and human health implications. Acta Trop. 83:7-11. http://dx.doi.org/10.1016/S0001-706X(02)00057-8.
23. Puzelli S, Di Trani L, Fabiani C, Campitelli L, De Marco MA, Capua I, Aguilera JF, Zambon M, Donatelli I. 2005. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J. Infect. Dis. 192:1318-1322. http://dx.doi.org/10.1086/444390.
24. Rigoni M, Shinya K, Toffan A, Milani A, Bettini F, Kawaoka Y, Cattoli G, Capua I. 2007. Pneumo- and neurotropism of avian origin Italian highly pathogenic avian influenza H7N1 isolates in experimentally infected mice. Virology 364:28-35. http://dx.doi.org/10.1016/j.virol.2007.02.031.
25. Kimble JB, Sorrell E, Shao H, Martin PL, Perez DR. 2011. Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model. Proc. Natl. Acad. Sci. U. S. A. 108:12084-12088. http://dx.doi.org/10.1073/pnas.1108058108.
26. Song H, Wan H, Araya Y, Perez DR. 2009. Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity. Virol. J. 6:126. http://dx.doi.org/10.1186/1743-422X-6-126.
27. Sorrell EM, Wan H, Araya Y, Song H, Perez DR. 2009. Minimal molecular constraints for respiratory droplet transmission of an avianhuman H9N2 influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 106:7565-7570. http://dx.doi.org/10.1073/pnas.0900877106.
28. Pena L, Sutton T, Chockalingam A, Kumar S, Angel M, Shao H, Chen H, Li W, Perez DR. 2013. Influenza viruses with rearranged genomes as live-attenuated vaccines. J. Virol. 87:5118-5127. http://dx.doi.org/10.1128/JVI.02490-12.
29. Djikeng A, Halpin R, Kuzmickas R, Depasse J, Feldblyum J, Sengamalay N, Afonso C, Zhang X, Anderson NG, Ghedin E, Spiro DJ. 2008. Viral genome sequencing by random priming methods. BMC Genomics 9:5. http://dx.doi.org/10.1186/1471-2164-9-5.
30. Beato MS, Monne I, Mancin M, Bertoli E, Capua I. 2010. A proof-of-principle study to identify suitable vaccine seed candidates to combat introductions of Eurasian lineage H5 and H7 subtype avian influenza viruses. Avian Pathol. 39:375-382. http://dx.doi.org/10.1080/03079457.2010.513376.
31. Min JY, Vogel L, Matsuoka Y, Lu B, Swayne D, Jin H, Kemble G, Subbarao K. 2010. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J. Virol. 84:11950-11960. http://dx.doi.org/10.1128/JVI.01305-10.
32. Banks J, Speidel ES, Moore E, Plowright L, Piccirillo A, Capua I, Cordioli P, Fioretti A, Alexander DJ. 2001. Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch. Virol. 146:963-973. http://dx.doi.org/10.1007/s007050170128.
33. Colman PM, Varghese JN, Laver WG. 1983. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303:41-44. http://dx.doi.org/10.1038/303041a0.
34. Gambaryan AS, Matrosovich TY, Philipp J, Munster VJ, Fouchier RA, Cattoli G, Capua I, Krauss SL, Webster RG, Banks J, Bovin NV, Klenk HD, Matrosovich MN. 2012. Receptor-binding profiles of H7 subtype influenza viruses in different host species. J. Virol. 86:4370-4379. http://dx.doi.org/10.1128/JVI.06959-11.
35. Zaraket H, Bridges OA, Duan S, Baranovich T, Yoon SW, Reed ML, Salomon R, Webby RJ, Webster RG, Russell CJ. 2013. Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets. J. Virol. 87:9911-9922. http://dx.doi.org/10.1128/JVI.01175-13.
36. Shelton H, Roberts KL, Molesti E, Temperton N, Barclay WS. 2013. Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility. J. Gen. Virol. 94:1220-1229. http://dx.doi.org/10.1099/vir.0.050526-0.
37. Naffakh N, Tomoiu A, Rameix-Welti MA, van der Werf S. 2008. Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu. Rev. Microbiol. 62:403-424. http://dx.doi.org/10.1146/annurev.micro.62.081307.162746.
38. Mänz B, Schwemmle M, Brunotte L. 2013. Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier. J. Virol. 87:7200-7209. http://dx.doi.org/10.1128/JVI.00980-13.
39. Brown EG, Liu H, Kit LC, Baird S, Nesrallah M. 2001. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl. Acad. Sci. U. S. A. 98:6883-6888. http://dx.doi.org/10.1073/pnas.111165798.
40. Gabriel G, Czudai-Matwich V, Klenk HD. 2013. Adaptive mutations in the H5N1 polymerase complex. Virus Res. 178:53-62. http://dx.doi.org/10.1016/j.virusres.2013.05.010.
41. Gabriel G, Herwig A, Klenk HD. 2008. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog. 4:e11. http://dx.doi.org/10.1371/journal.ppat.0040011.
42. Hudjetz B, Gabriel G. 2012. Human-like PB2 627K influenza virus polymerase activity is regulated by importin-alpha1 and -alpha7. PLoS Pathog. 8:e1002488. http://dx.doi.org/10.1371/journal.ppat.1002488.
43. Gabriel G, Klingel K, Otte A, Thiele S, Hudjetz B, Arman-Kalcek G, Sauter M, Shmidt T, Rother F, Baumgarte S, Keiner B, Hartmann E, Bader M, Brownlee GG, Fodor E, Klenk HD. 2011. Differential use of importin-alpha isoforms governs cell tropism and host adaptation of influenza virus. Nat. Commun. 2:156. http://dx.doi.org/10.1038/ncomms1158.
44. Miotto O, Heiny AT, Albrecht R, Garcia-Sastre A, Tan TW, August JT, Brusic V. 2010. Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One 5:e9025. http://dx.doi.org/10.1371/journal.pone.0009025.
45. Li J, Ishaq M, Prudence M, Xi X, Hu T, Liu Q, Guo D. 2009. Single mutation at the amino acid position 627 of PB2 that leads to increased virulence of an H5N1 avian influenza virus during adaptation in mice can be compensated by multiple mutations at other sites of PB2. Virus Res. 144:123-129. http://dx.doi.org/10.1016/j.virusres.2009.04.008.
46. Chen GW, Chang SC, Mok CK, Lo YL, Kung YN, Huang JH, Shih YH, Wang JY, Chiang C, Chen CJ, Shih SR. 2006. Genomic signatures of human versus avian influenzaAviruses. Emerg. Infect. Dis. 12:1353-1360. http://dx.doi.org/10.3201/eid1209.060276.
47. Jorba N, Juarez S, Torreira E, Gastaminza P, Zamarreno N, Albar JP, Ortin J. 2008. Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics 8:2077-2088. http://dx.doi.org/10.1002/pmic.200700508.
48. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267. http://dx.doi.org/10.1016/j.cell.2009.12.018.
49. Tafforeau L, Chantier T, Pradezynski F, Pellet J, Mangeot PE, Vidalain PO, Andre P, Rabourdin-Combe C, Lotteau V. 2011. Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network. J. Virol. 85:13010-13018. http://dx.doi.org/10.1128/JVI.02651-10.
50. Hurt AC, Deng YM, Ernest J, Caldwell N, Leang L, Iannello P, Komadina N, Shaw R, Smith D, Dwyer DE, Tramontana AR, Lin RT, Freeman K, Kelso A, Barr IG. 2011. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill. 16:19770. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19770.
51. Lackenby A, Moran Gilad J, Pebody R, Miah S, Calatayud L, Bolotin S, Vipond I, Muir P, Guiver M, McMenamin J, Reynolds A, Moore C, Gunson R, Thompson C, Galiano M, Bermingham A, Ellis J, Zambon M. 2011. Continued emergence and changing epidemiology of oseltamivir- resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill. 16:19784. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19784.
52. Ujike M, Ejima M, Anraku A, Shimabukuro K, Obuchi M, Kishida N, Hong X, Takashita E, Fujisaki S, Yamashita K, Horikawa H, Kato Y, Oguchi A, Fujita N, Tashiro M, Odagiri T. 2011. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerg. Infect. Dis. 17:470-479. http://dx.doi.org/10.3201/eid1703.101188.
53. Kao RY, Yang D, Lau LS, Tsui WH, Hu L, Dai J, Chan MP, Chan CM, Wang P, Zheng BJ, Sun J, Huang JD, Madar J, Chen G, Chen H, Guan Y, Yuen KY. 2010. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 28:600-605. http://dx.doi.org/10.1038/nbt.1638.
54. Cheng H, Wan J, Lin MI, Liu Y, Lu X, Liu J, Xu Y, Chen J, Tu Z, Cheng YS, Ding K. 2012. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein. J. Med. Chem. 55:2144-2153. http://dx.doi.org/10.1021/jm2013503.
55. Gerritz SW, Cianci C, Kim S, Pearce BC, Deminie C, Discotto L, McAuliffe B, Minassian BF, Shi S, Zhu S, Zhai W, Pendri A, Li G, Poss MA, Edavettal S, McDonnell PA, Lewis HA, Maskos K, Mortl M, Kiefersauer R, Steinbacher S, Baldwin ET, Metzler W, Bryson J, Healy MD, Philip T, Zoeckler M, Schartman R, Sinz M, Leyva-Grado VH, Hoffmann HH, Langley DR, Meanwell NA, Krystal M. 2011. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers. Proc. Natl. Acad. Sci. U. S. A. 108:15366-15371. http://dx.doi.org/10.1073/pnas.1107906108.
56. Massari S, Nannetti G, Goracci L, Sancineto L, Muratore G, Sabatini S, Manfroni G, Mercorelli B, Cecchetti V, Facchini M, Palu G, Cruciani G, Loregian A, Tabarrini O. 2013. Structural investigation of cycloheptathiophene- 3-carboxamide derivatives targeting influenza virus polymerase assembly. J. Med. Chem. 56:10118-10131. http://dx.doi.org/10.1021/jm401560v.
57. Tintori C, Laurenzana I, Fallacara AL, Kessler U, Pilger B, Stergiou L, Botta M. 2014. High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 proteinprotein interaction. Bioorg. Med. Chem. Lett. 24:280-282. http://dx.doi.org/10.1016/j.bmcl.2013.11.019.
58. Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, Ruigrok RW, Di Primo C, Slama-Schwok A. 2013. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrob. Agents Chemother. 57:2231-2242. http://dx.doi.org/10.1128/AAC.02335-12.
59. Angel M, Kimble JB, Pena L, Wan H, Perez DR. 2013. In vivo selection of H1N2 influenza virus reassortants in the ferret model. J. Virol. 87:3277-3283. http://dx.doi.org/10.1128/JVI.02591-12.
60. Lakdawala SS, Lamirande EW, Suguitan AL, Jr, Wang W, Santos CP, Vogel L, Matsuoka Y, Lindsley WG, Jin H, Subbarao K. 2011. Eurasianorigin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog. 7:e1002443. http://dx.doi.org/10.1371/journal.ppat.1002443.
61. Campbell PJ, Danzy S, Kyriakis CS, Deymier MJ, Lowen AC, Steel J. 2014. The M segment of the 2009 pandemic influenza virus confers increased NA activity, filamentous morphology and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses. J. Virol. 88:3802-3814. http://dx.doi.org/10.1128/JVI.03607-13.
62. Bourmakina SV, Garcia-Sastre A. 2003. Reverse genetics studies on the filamentous morphology of influenza A virus. J. Gen. Virol. 84:517-527. http://dx.doi.org/10.1099/vir.0.18803-0.
63. Baudin F, Petit I, Weissenhorn W, Ruigrok RW. 2001. In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology 281:102-108. http://dx.doi.org/10.1006/viro.2000.0804.
64. Couch RB, Patel SM, Wade-Bowers CL, Nino D. 2012. A randomized clinical trial of an inactivated avian influenzaA(H7N7) vaccine. PLoS One 7:e49704. http://dx.doi.org/10.1371/journal.pone.0049704.
65. Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, Garcia- Sastre A, Palese P. 2014. Divergent H7 immunogens offer protection from H7N9 challenge. J. Virol. 88:3976-3985. http://dx.doi.org/10.1128/JVI.03095-13.
66. Treanor J. 2013, posting date. Evaluating the safety and immune response of an H7N7 vaccine in healthy adults. http://www.clinicaltrials.gov/ct2/show/NCT01534468.
67. Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, Bi Y, Wu Y, Li X, Yan J, Liu W, Zhao G, Yang W, Wang Y, Ma J, Shu Y, Lei F, Gao GF. 2013. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 381:1926-1932. http://dx.doi.org/10.1016/S0140-6736(13)60938-1.
68. Perez DR, Sorrell E, Angel M, Ye J, Hickman D, Pena L, Ramirez-Nieto G, Kimble B, Araya Y. 2009. Fitness of pandemic H1N1 and seasonal influenza A viruses during co-infection: evidence of competitive advantage of pandemic H1N1 influenza versus seasonal influenza. PLoS Curr. 1:RRN1011. http://dx.doi.org/10.1371/currents. RRN1011.
69. Yang H, Chen LM, Carney PJ, Donis RO, Stevens J. 2010. Structures of receptor complexes of a North American H7N2 influenza hemagglutinin with a loop deletion in the receptor binding site. PLoS Pathog. 6:e1001081. http://dx.doi.org/10.1371/journal.ppat.1001081.
70. Hale BG, Randall RE, Ortin J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89:2359-2376. http://dx.doi.org/10.1099/vir.0.2008/004606-0.